Literature DB >> 21554219

Physiological changes in the critically ill patient with sepsis.

Shaun Hosein1, Andrew A Udy, Jeffrey Lipman.   

Abstract

Intensive care medicine deals with the critically ill; these patients usually have multiple organ failure, and complex medical conditions. The mortality in Australia and New Zealand among this population is approximately 16.1%, with approximately 24.2% having existing co-morbidities, and 23.4% of these patients experiencing sepsis or septic shock. Sepsis is a clinical syndrome that traditionally was regarded as a physiological maladaptive response to a foreign pathogen and ranges in disease severity from simple sepsis to septic shock, a life threatening condition, associated with multiple organ failure. Sepsis has profound effects on all systems of the body, and most notably the cardiovascular, renal and hepatic systems. There has been much research into the septic critically ill patient and recent developments in basic pharmacology and physiology has yielded results applicable to clinical practice. Sepsis may induce a state of increased cardiac output, which has significant effects on drug pharmacokinetics and pharmacodynamics. This increased cardiac output increases both renal and hepatic blood flow, and alters rates of antibiotic metabolism, and excretion. There are also alterations in the fluid compartments of the septic critically ill, that results in an altered volume of distribution, and ultimately decreased antibiotic concentrations at their site of action. This article will examine and review in detail the septic critically ill patient, and the effects that sepsis has on physiology and the resulting altered antibiotic pharmacokinetics and pharmacodynamics. Current knowledge suggests that the medical prescriber should be weary of antibiotic dosing in the septic critically ill, and consider alternative dosing regimes that are individualized to the patient in order to maximize efficacy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554219     DOI: 10.2174/138920111798808248

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  8 in total

1.  Serum levels of daptomycin in pediatric patients.

Authors:  C Antachopoulos; E Iosifidis; K Sarafidis; F Bazoti; E Gikas; A Katragkou; V Drossou-Agakidou; E Roilides
Journal:  Infection       Date:  2012-01-21       Impact factor: 3.553

Review 2.  Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.

Authors:  Brenda Ng Andriolo; Regis B Andriolo; Reinaldo Salomão; Álvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2017-01-18

3.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

4.  Pharmacokinetics of tulathromycin in pregnant ewes (Ovis aries) challenged with Campylobacter jejuni.

Authors:  Michael Yaeger; Jonathan P Mochel; Zuowei Wu; Paul Plummer; Orhan Sahin; Joseph Smith; Melda Ocal; Ashenafi Beyi; Changyun Xu; Qijing Zhang; Ronald W Griffith
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

5.  Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Authors:  Andrew A Udy; Jeffrey Lipman; Paul Jarrett; Kerenaftali Klein; Steven C Wallis; Kashyap Patel; Carl M J Kirkpatrick; Peter S Kruger; David L Paterson; Michael S Roberts; Jason A Roberts
Journal:  Crit Care       Date:  2015-01-30       Impact factor: 9.097

6.  Macro- and micronutrient disposition in an ex vivo model of extracorporeal membrane oxygenation.

Authors:  Kristine Estensen; Kiran Shekar; Elissa Robins; Charles McDonald; Adrian G Barnett; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2014-11-22

7.  A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations.

Authors:  Andrew A Udy; Fraser J A Morton; Sallyanne Nguyen-Pham; Paul Jarrett; Melissa Lassig-Smith; Janine Stuart; Rachel Dunlop; Therese Starr; Robert J Boots; Jeffrey Lipman
Journal:  BMC Nephrol       Date:  2013-11-13       Impact factor: 2.388

8.  Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study.

Authors:  Seth K Amponsah; George O Adjei; Christabel Enweronu-Laryea; Kwasi A Bugyei; Kosta Hadji-Popovski; Jorgen A L Kurtzhals; Kim Kristensen
Journal:  Curr Ther Res Clin Exp       Date:  2017-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.